Intuitive Surgical is a pioneering medical device company specializing in robotic-assisted surgical systems, most notably the da Vinci Surgical System. This innovative platform enhances the precision and control of minimally invasive surgical procedures, enabling surgeons to perform operations with greater accuracy and reduced recovery times for patients. The company is dedicated to advancing the field of robotics in surgery, providing training and support for healthcare professionals, and continually innovating its technology to improve patient outcomes across various medical specialties. Read More
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at surgical equipment & consumables - specialty stocks, starting with Intuitive Surgical (NASDAQ:ISRG).
The stock market is currently experiencing a profound transformation, driven by the relentless rise of Artificial Intelligence (AI). This technological revolution is not merely a fleeting trend but a fundamental shift, propelling unprecedented growth within the tech sector and attracting colossal investments from industry titans. The immediate implications are clear:
The U.S. and Japan announced a big trade deal that lowers tariffs to just 15% on imports, and the team discusses earnings from General Motors, Intuitive Surgical, and Enphase Energy.
The Nasdaq 100 (^NDX) is known for housing some of the most innovative and fastest-growing companies in the market.
But not every stock in the index is a winner - some are struggling with slowing growth, increasing competition, or unsustainable valuations.
Medical technology company Intuitive Surgical (NASDAQ:ISRG) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 21.4% year on year to $2.44 billion. Its non-GAAP profit of $2.19 per share was 14.2% above analysts’ consensus estimates.
Robotics healthcare giant Intuitive Surgical handily beat expectations in Q2. Shares stayed flat; the bullish long-term outlook for this stock rides on.
A wave of U.S. trade deals with key allies over the past 24 hours reignited Wall Street's rally and boosted investor risk appetite across global markets.
Medical technology company Intuitive Surgical (NASDAQ:ISRG) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 21.4% year on year to $2.44 billion. Its non-GAAP profit of $2.19 per share was 14.3% above analysts’ consensus estimates.
SUNNYVALE, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended June 30, 2025.
